Lang Jesse T, Kassan Thomas O, Devaney Laurie Lee, Colon-Semenza Cristina, Joseph Michael F
Doctor of Physical Therapy Program, Department of Kinesiology, College of Agriculture, Health and Natural Resources, University of Connecticut, Storrs.
J Geriatr Phys Ther. 2016 Oct-Dec;39(4):165-70. doi: 10.1519/JPT.0000000000000068.
Measurement of gait performance in individuals with Parkinson's disease (PD) can be challenging because of the daily fluctuations in performance and the progressive nature of the condition. The 10-Meter Walk Test (10MWT) is commonly used to measure gait speed of individuals with gait limitations. Existing research on the 10MWT in individuals with PD controls for many variables inherent to this condition, rendering the results of this test in settings where these variables are not controlled questionable. The purpose of this study was to estimate under commonly encountered clinical conditions the test-retest reliability and the minimal detectable change (MDC) of gait speed and step frequency determined during the 10MWT in individuals with PD.
The 10MWT was administered by 2 testers, on 35 participants, across 2 sessions, separated by 5 to 14 days. Gait speed was measured using a hand-held stopwatch, and step frequency was assessed through visual observation. Test-retest reliability was calculated using the intraclass correlation coefficient (ICC) and the MDC was calculated using the standard error of measurement (SEM).
Comfortable and fast gait speeds demonstrated excellent reliability between sessions (ICC = 0.92 and 0.96, respectively). The corresponding MDCs were 0.22 and 0.23 m/s, respectively. The test-retest reliability for step frequency was moderate for comfortable gait speed and good for fast gait speeds (ICC = 0.73 and 0.82, respectively). The corresponding MDCs were 15.1 and 17.4 steps per minute for comfortable and fast step frequency, respectively.
Under both comfortable and fast conditions, measurements of gait speed and step frequency during the 10MWT are reliable between sessions in individuals with PD.
帕金森病(PD)患者的步态表现测量具有挑战性,因为其表现存在日常波动且病情呈进行性发展。10米步行测试(10MWT)常用于测量有步态限制的个体的步速。现有关于PD患者10MWT的研究控制了该疾病固有的许多变量,使得在这些变量未得到控制的情况下该测试的结果存疑。本研究的目的是在常见的临床条件下,估计PD患者在10MWT期间测定的步速和步频的重测信度以及最小可检测变化(MDC)。
由2名测试人员对35名参与者进行10MWT测试,分2个阶段进行,间隔5至14天。使用手持秒表测量步速,通过视觉观察评估步频。使用组内相关系数(ICC)计算重测信度,使用测量标准误差(SEM)计算MDC。
舒适步态速度和快速步态速度在各阶段之间显示出极佳的信度(ICC分别为0.92和0.96)。相应的MDC分别为0.22和0.23米/秒。舒适步态速度下步频的重测信度中等,快速步态速度下良好(ICC分别为0.73和0.82)。舒适步频和快速步频下相应的MDC分别为每分钟15.1步和17.4步。
在舒适和快速两种条件下,PD患者在10MWT期间的步速和步频测量在各阶段之间都是可靠的。